|
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing |
Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing. Journal of the National Cancer Institute 2015; 107(1) Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; BRCA1 Protein /genetics; BRCA2 Protein /genetics; Breast Neoplasms /economics /genetics /prevention & Cost-Benefit Analysis; Early Detection of Cancer /economics /methods; Female; Genetic Testing /economics /methods; Great Britain; Humans; Jews /genetics; Mass Screening /economics /methods; Middle Aged; Mutation; Ovarian Neoplasms /economics /genetics /prevention & Quality of Life; Quality-Adjusted Life Years; Sensitivity and Specificity; control; control AccessionNumber 22014043820 Date bibliographic record published 11/02/2015 |
|
|
|